Immix Biopharma
IMMX
#7157
Rank
A$0.88 B
Marketcap
A$10.52
Share price
-1.14%
Change (1 day)
56.84%
Change (1 year)

Earnings for Immix Biopharma (IMMX)

Earnings in 2026 (TTM): -A$61.49 Million

According to Immix Biopharma's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$45.26 Million a decrease over its 2024 earnings that were of -A$34.26 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Immix Biopharma from 2021 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$61.49 Million35.85%
2025 -A$45.26 Million32.11%
2024 -A$34.26 Million42.5%
2023 -A$24.05 Million93.61%
2022 -A$12.42 Million-66.03%
2021 -A$36.56 Million